Zurzuvae Will Be a New Rx for Postpartum Depression

February 2024

New Rx zuranolone (Zurzuvae) will be the first oral med approved for treatment of postpartum depression.

Zuranolone starts to improve depression symptoms within days.

This is quicker than SSRIs (sertraline, etc) for postpartum depression...which take at least 1 to 2 weeks to start working. Plus most SSRIs need to be taken daily.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Med Safety Prevent Problems With Meds That Can Catch Fire
Women's Health Zurzuvae Will Be a New Rx for Postpartum Depression
Migraine Avoid Mix-Ups With “Gepant” Rxs for Migraine
Acetaminophen Revisit Acetaminophen Safety
Medication Errors Use Error Reports as a Tool to Enhance Safety
COPD Take Steps to Keep Patients With COPD Out of the Hospital
Injectables Help Patients Overcome Hurdles With GLP-1 Agonists
NatMed Spotlight Answer Questions About Cocoa for Heart Health or Cognition

Zurzuvae Will Be a New Rx for Postpartum Depression

Practical advice for a better career, with unlimited access to CE

Table of Contents